Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside

Vijaya L. Damaraju, Frank Visser, Jing Zhang, Delores Mowles, Amy M.L. Ng, James D. Young, Hiremagalur N. Jayaram, Carol E. Cass

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Benzamide riboside (BR) and tiazofurin (TR) are converted to analogs of NAD that inhibit IMP dehydrogenase (IMPDH), resulting in cellular depletion of GTP and dGTP and inhibition of proliferation. The current work was undertaken to identify the human nucleoside transporters involved in cellular uptake of BR and TR and to evaluate their role in cytotoxicity. Transportability was examined in Xenopus laevis oocytes and Saccharomyces cerevisiae that produced individual recombinant human concentrative nucleoside transporter (CNT) and equilibrative nucleoside transporter (ENT) types (hENT1, hENT2, hCNT1, hCNT2, or hCNT3). TR was a better permeant than BR with a rank order of transportability in oocytes of hCNT3 ≫ hENT1 > hENT2 > hCNT2 ≫ hCNT1. The concentration dependence of inhibition of [3H]uridine transport in S. cerevisiae by TR exhibited lower Ki values than BR: hCNT3 (5.4 versus 226 μM), hENT2 (16 versus 271 μM), hENT1 (57 versus 168 μM), and hCNT1 (221 versus 220 μM). In cytotoxicity experiments, BR was more cytotoxic than TR to cells that were either nucleoside transport-defective or -competent, and transport-competent cells were more sensitive to both drugs. Exposure to nitrobenzylmercaptopurine ribonucleoside conferred resistance to BR and TR cytotoxicity to hENT1-containing CEM cells, thereby demonstrating the importance of transport capacity for manifestation of cytoxicity. A breast cancer cell line with mutant p53 exhibited 9-fold higher sensitivity to BR than the otherwise similar cell line with wild-type p53, suggesting that cells with mutant p53 may be potential targets for IMPDH inhibitors. Further studies are warranted to determine whether this finding can be generalized to other cell types.

Original languageEnglish (US)
Pages (from-to)273-279
Number of pages7
JournalMolecular Pharmacology
Volume67
Issue number1
DOIs
StatePublished - Jan 1 2005

Fingerprint

tiazofurin
IMP Dehydrogenase
Nucleoside Transport Proteins
Oocytes
Saccharomyces cerevisiae
Ribonucleosides
Cell Line
Uridine
Xenopus laevis
Guanosine Triphosphate
3-(1-deoxyribofuranosyl)benzamide
Nucleosides
NAD

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside. / Damaraju, Vijaya L.; Visser, Frank; Zhang, Jing; Mowles, Delores; Ng, Amy M.L.; Young, James D.; Jayaram, Hiremagalur N.; Cass, Carol E.

In: Molecular Pharmacology, Vol. 67, No. 1, 01.01.2005, p. 273-279.

Research output: Contribution to journalArticle

Damaraju, VL, Visser, F, Zhang, J, Mowles, D, Ng, AML, Young, JD, Jayaram, HN & Cass, CE 2005, 'Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside', Molecular Pharmacology, vol. 67, no. 1, pp. 273-279. https://doi.org/10.1124/mol.104.004408
Damaraju, Vijaya L. ; Visser, Frank ; Zhang, Jing ; Mowles, Delores ; Ng, Amy M.L. ; Young, James D. ; Jayaram, Hiremagalur N. ; Cass, Carol E. / Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside. In: Molecular Pharmacology. 2005 ; Vol. 67, No. 1. pp. 273-279.
@article{2ce732d20b5744b7bf6dcdf9a556445b,
title = "Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside",
abstract = "Benzamide riboside (BR) and tiazofurin (TR) are converted to analogs of NAD that inhibit IMP dehydrogenase (IMPDH), resulting in cellular depletion of GTP and dGTP and inhibition of proliferation. The current work was undertaken to identify the human nucleoside transporters involved in cellular uptake of BR and TR and to evaluate their role in cytotoxicity. Transportability was examined in Xenopus laevis oocytes and Saccharomyces cerevisiae that produced individual recombinant human concentrative nucleoside transporter (CNT) and equilibrative nucleoside transporter (ENT) types (hENT1, hENT2, hCNT1, hCNT2, or hCNT3). TR was a better permeant than BR with a rank order of transportability in oocytes of hCNT3 ≫ hENT1 > hENT2 > hCNT2 ≫ hCNT1. The concentration dependence of inhibition of [3H]uridine transport in S. cerevisiae by TR exhibited lower Ki values than BR: hCNT3 (5.4 versus 226 μM), hENT2 (16 versus 271 μM), hENT1 (57 versus 168 μM), and hCNT1 (221 versus 220 μM). In cytotoxicity experiments, BR was more cytotoxic than TR to cells that were either nucleoside transport-defective or -competent, and transport-competent cells were more sensitive to both drugs. Exposure to nitrobenzylmercaptopurine ribonucleoside conferred resistance to BR and TR cytotoxicity to hENT1-containing CEM cells, thereby demonstrating the importance of transport capacity for manifestation of cytoxicity. A breast cancer cell line with mutant p53 exhibited 9-fold higher sensitivity to BR than the otherwise similar cell line with wild-type p53, suggesting that cells with mutant p53 may be potential targets for IMPDH inhibitors. Further studies are warranted to determine whether this finding can be generalized to other cell types.",
author = "Damaraju, {Vijaya L.} and Frank Visser and Jing Zhang and Delores Mowles and Ng, {Amy M.L.} and Young, {James D.} and Jayaram, {Hiremagalur N.} and Cass, {Carol E.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1124/mol.104.004408",
language = "English (US)",
volume = "67",
pages = "273--279",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside

AU - Damaraju, Vijaya L.

AU - Visser, Frank

AU - Zhang, Jing

AU - Mowles, Delores

AU - Ng, Amy M.L.

AU - Young, James D.

AU - Jayaram, Hiremagalur N.

AU - Cass, Carol E.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Benzamide riboside (BR) and tiazofurin (TR) are converted to analogs of NAD that inhibit IMP dehydrogenase (IMPDH), resulting in cellular depletion of GTP and dGTP and inhibition of proliferation. The current work was undertaken to identify the human nucleoside transporters involved in cellular uptake of BR and TR and to evaluate their role in cytotoxicity. Transportability was examined in Xenopus laevis oocytes and Saccharomyces cerevisiae that produced individual recombinant human concentrative nucleoside transporter (CNT) and equilibrative nucleoside transporter (ENT) types (hENT1, hENT2, hCNT1, hCNT2, or hCNT3). TR was a better permeant than BR with a rank order of transportability in oocytes of hCNT3 ≫ hENT1 > hENT2 > hCNT2 ≫ hCNT1. The concentration dependence of inhibition of [3H]uridine transport in S. cerevisiae by TR exhibited lower Ki values than BR: hCNT3 (5.4 versus 226 μM), hENT2 (16 versus 271 μM), hENT1 (57 versus 168 μM), and hCNT1 (221 versus 220 μM). In cytotoxicity experiments, BR was more cytotoxic than TR to cells that were either nucleoside transport-defective or -competent, and transport-competent cells were more sensitive to both drugs. Exposure to nitrobenzylmercaptopurine ribonucleoside conferred resistance to BR and TR cytotoxicity to hENT1-containing CEM cells, thereby demonstrating the importance of transport capacity for manifestation of cytoxicity. A breast cancer cell line with mutant p53 exhibited 9-fold higher sensitivity to BR than the otherwise similar cell line with wild-type p53, suggesting that cells with mutant p53 may be potential targets for IMPDH inhibitors. Further studies are warranted to determine whether this finding can be generalized to other cell types.

AB - Benzamide riboside (BR) and tiazofurin (TR) are converted to analogs of NAD that inhibit IMP dehydrogenase (IMPDH), resulting in cellular depletion of GTP and dGTP and inhibition of proliferation. The current work was undertaken to identify the human nucleoside transporters involved in cellular uptake of BR and TR and to evaluate their role in cytotoxicity. Transportability was examined in Xenopus laevis oocytes and Saccharomyces cerevisiae that produced individual recombinant human concentrative nucleoside transporter (CNT) and equilibrative nucleoside transporter (ENT) types (hENT1, hENT2, hCNT1, hCNT2, or hCNT3). TR was a better permeant than BR with a rank order of transportability in oocytes of hCNT3 ≫ hENT1 > hENT2 > hCNT2 ≫ hCNT1. The concentration dependence of inhibition of [3H]uridine transport in S. cerevisiae by TR exhibited lower Ki values than BR: hCNT3 (5.4 versus 226 μM), hENT2 (16 versus 271 μM), hENT1 (57 versus 168 μM), and hCNT1 (221 versus 220 μM). In cytotoxicity experiments, BR was more cytotoxic than TR to cells that were either nucleoside transport-defective or -competent, and transport-competent cells were more sensitive to both drugs. Exposure to nitrobenzylmercaptopurine ribonucleoside conferred resistance to BR and TR cytotoxicity to hENT1-containing CEM cells, thereby demonstrating the importance of transport capacity for manifestation of cytoxicity. A breast cancer cell line with mutant p53 exhibited 9-fold higher sensitivity to BR than the otherwise similar cell line with wild-type p53, suggesting that cells with mutant p53 may be potential targets for IMPDH inhibitors. Further studies are warranted to determine whether this finding can be generalized to other cell types.

UR - http://www.scopus.com/inward/record.url?scp=11244273057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11244273057&partnerID=8YFLogxK

U2 - 10.1124/mol.104.004408

DO - 10.1124/mol.104.004408

M3 - Article

C2 - 15486050

AN - SCOPUS:11244273057

VL - 67

SP - 273

EP - 279

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -